Enovis CORP (ENOV) Stock
4 of the hedge funds AlphaScala tracks reported ENOV in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Millennium Management's at $16.63M. Company insiders reported 4 open-market buys and 0 sales on SEC Form 4 in the 90 days to Oct 21, 2026.
Which hedge funds own ENOV?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Millennium Management Israel Englander | 803K | $16.63M | +28% |
| Marshall Wace | 294K | $6.10M | +13% |
| D.E. Shaw David Shaw | 84K | $1.73M | -18% |
| Bridgewater Associates Ray Dalio | 77K | $1.60M | +50% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are Enovis CORP insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Sep 4, 26 | Mcdonald Damien | Chief Executive Officer | BUY | 13.0K | $250K |
| Sep 4, 26 | Engert Oliver | Chief Administrative Officer | BUY | 2.7K | $50K |
| Sep 3, 26 | Engert Oliver | Chief Administrative Officer | BUY | 5.1K | $100K |
| Sep 2, 26 | Engert Oliver | Chief Administrative Officer | BUY | 2.5K | $50K |
SEC Form 4 filings as of Oct 21, 2026
See cluster-buy signals across all tickers →ENOV price chart
Powered by TradingViewWhat does Enovis CORP do?
Enovis Corporation is a diversified healthcare equipment company focused on developing and supplying a broad range of innovative medical technology solutions. The primary function of the company is to enhance patient care and improve treatment outcomes across various medical specialties. Enovis is known for its advanced surgical solutions, rehabilitation devices, and other healthcare innovations that serve both healthcare providers and patients. The company's products cater to sectors such as orthopedics, pain management, and wound care, offering a significant impact on surgical efficiencies and patient recovery. By providing a comprehensive portfolio of medical solutions, Enovis plays a vital role in the healthcare industry, supporting the demands of hospitals, clinics, and healthcare professionals. In the financial market, Enovis Corporation holds significance as it merges cutting-edge technology with healthcare services, contributing to the advancement of medical science and the betterment of patient-centric care. Its commitment to research and development underscores its role in shaping the future of healthcare, offering both therapeutic benefits and operational efficiencies.